SCHEMBL4768407

SCHEMBL4768407

CCN1CCN(c2nc(-c3cccc(OC)c3)cc3ccccc23)CC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.52
CYP2D6 P10635 3/20 0.52
CYP1A2 P05177 3/20 0.52
CYP3A4 P08684 2/20 0.52
USP2 O75604 2/20 0.52
MAPK1 P28482 2/20 0.52
CLK4 Q9HAZ1 1/20 0.52
ABCG2 Q9UNQ0 1/20 0.50
LMNA P02545 3/20 0.48
HPGD P15428 2/20 0.48
MAPT P10636 2/20 0.48
ALDH1A1 P00352 1/20 0.48
HSD17B10 Q99714 1/20 0.48
TP53 P04637 2/20 0.48
CNR1 P21554 1/20 0.47
CNR2 P34972 1/20 0.47
WNK1 Q9H4A3 1/20 0.46
KDM4E B2RXH2 2/20 0.46
GAA P10253 1/20 0.46
KMT2A Q03164 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4764011 0.99 TSHR (0.51) TSHRCYP2D6CYP1A2CYP3A4USP2
SCHEMBL6288933 0.95 CYP2D6 (0.49) TSHRCYP2D6CYP1A2CYP3A4USP2
SCHEMBL4774077 0.91 SMN1; SMN2 (0.46) TSHRCYP2D6CYP1A2CYP3A4USP2
Hydrochloric Acid SCHEMBL4768944 0.90 SMN1; SMN2 (0.45) TSHRCYP2D6CYP1A2CYP3A4USP2
SCHEMBL4763566 0.89 HRH3 (0.48) CYP1A2LMNAHPGDMAPTALDH1A1
Hydrochloric Acid SCHEMBL4770729 0.88 HRH3 (0.47) TSHRCYP1A2LMNAHPGDMAPT
SCHEMBL4772897 0.87 CYP2D6 (0.44) TSHRCYP2D6CYP1A2CYP3A4USP2
Hydrochloric Acid SCHEMBL4772191 0.86 CYP2D6 (0.43) TSHRCYP2D6CYP1A2CYP3A4USP2
SCHEMBL4767067 0.85 CYP2D6 (0.47) TSHRCYP2D6CYP1A2CYP3A4USP2
SCHEMBL4768596 0.85 SMN1; SMN2 (0.46) LMNAMAPTKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020013460-A1 Condensed pyridine compound EISAI CO., LTD 2002-01-31 US claimed
EP-1020445-A1 FUSED PYRIDINE DERIVATIVES Eisai Co., Ltd. (JP) 2000-07-19 EP claimed
EP-1020445-B1 FUSED PYRIDINE DERIVATIVES EISAI R&D MAN CO LTD (JP) 2008-08-13 EP disclosed
US-6875761-B2 Certain 1,3-disubstituted isoquinoline derivatives EISAI CO., LTD. (JP) 2005-04-05 US disclosed
US-20040204421-A1 Certain 1,3-disubstituted isoquinoline derivatives EISAI CO., LTD. 2004-10-14 US disclosed
US-6790844-B2 MUSCLE RELAXANTS; ANTISEROTONINE AGENT EISAI CO., LTD (JP) 2004-09-14 US disclosed
US-20020013460-A1 Condensed pyridine compound EISAI CO., LTD 2002-01-31 US disclosed
US-6340759-B1 ANTISPASMODIC AGENTS EISAI CO., LTD. (JP) 2002-01-22 US disclosed
EP-1020445-A1 FUSED PYRIDINE DERIVATIVES Eisai Co., Ltd. (JP) 2000-07-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020013460-A1 Condensed pyridine compound MUSK, HTR1A, PAX3 TSHR 1481/4885CYP2D6 3573/4885CYP1A2 2126/4885
US-20040204421-A1 Certain 1,3-disubstituted isoquinoline derivatives MUSK, HTR1A, RYR1 TSHR 962/4885CYP2D6 2558/4885CYP1A2 1489/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.